Press Releases 3 Investor Relations Press Releases Events Presentations Press Releases Year None202120202019201820172016 Jan 19, 2021 DermTech Chief Scientific Officer Michael Howell Presented at Dermatology Summit 2021 Jan 14, 2021 DermTech Pigmented Lesion Assay (PLA) to Enrich Melanoma Positivity Nearly Five-Fold in Biopsied Lesions: Findings from a Large US Registry Jan 12, 2021 DermTech Announces Inclusion of Non-Invasive Genomic Patch Testing in the National Comprehensive Cancer Network® (NCCN) Cutaneous Melanoma Guidelines Jan 11, 2021 DermTech Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Jan 07, 2021 DermTech Announces Pricing of Public Offering of Common Stock Jan 06, 2021 DermTech Announces Proposed Public Offering of Common Stock Jan 05, 2021 DermTech Announces Appointment of General Counsel Investor Tools Print Email Page Email Alerts RSS Feeds Contact IR
Press Releases Year None202120202019201820172016 Jan 19, 2021 DermTech Chief Scientific Officer Michael Howell Presented at Dermatology Summit 2021 Jan 14, 2021 DermTech Pigmented Lesion Assay (PLA) to Enrich Melanoma Positivity Nearly Five-Fold in Biopsied Lesions: Findings from a Large US Registry Jan 12, 2021 DermTech Announces Inclusion of Non-Invasive Genomic Patch Testing in the National Comprehensive Cancer Network® (NCCN) Cutaneous Melanoma Guidelines Jan 11, 2021 DermTech Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Jan 07, 2021 DermTech Announces Pricing of Public Offering of Common Stock Jan 06, 2021 DermTech Announces Proposed Public Offering of Common Stock Jan 05, 2021 DermTech Announces Appointment of General Counsel
Jan 14, 2021 DermTech Pigmented Lesion Assay (PLA) to Enrich Melanoma Positivity Nearly Five-Fold in Biopsied Lesions: Findings from a Large US Registry
Jan 12, 2021 DermTech Announces Inclusion of Non-Invasive Genomic Patch Testing in the National Comprehensive Cancer Network® (NCCN) Cutaneous Melanoma Guidelines
Jan 11, 2021 DermTech Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
